Market News AIOpen the app

SGMT stock news · Sagimet Biosciences

Stories about Sagimet Biosciences (SGMT) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for SGMT

Follow Sagimet Biosciences (SGMT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SGMT
Free on the App Store and Google Play, or on the web.
  1. Nov 14, 2026, 9:07 PM ET · Opinion

    Canaccord Genuity still thinks Sagimet Biosciences is a good buy.

    Neutral

    Canaccord Genuity kept its Buy rating on Sagimet Biosciences on November 13, 2026. The report gives no new company details, so it adds no reason to change how we read the business.

  2. Nov 14, 2026, 9:06 PM ET · Market

    Someone just invested $950,000 in a call option for Sagimet Biosciences, showing big interest in the company’s future.

    Neutral

    Sagimet Biosciences saw a trader spend $950,000 on 5,000 call options with a $10 share-price threshold, expiring January 15, 2027. One trader's bet does not change the company's outlook.